Pre-extinction administration of D 9 -tetrahydrocannibinol (THC) facilitates recall of extinction in healthy humans, and evidence from animal studies suggest that this likely occurs via enhancement of the cannabinoid system within the ventromedial prefrontal cortex (vmPFC) and hippocampus (HIPP), brain structures critical to fear extinction. However, the effect of cannabinoids on the underlying neural circuitry of extinction memory recall in humans has not been demonstrated. We conducted a functional magnetic resonance imaging (fMRI) study using a randomized, double-blind, placebo-controlled, between-subjects design (N = 14/group) coupled with a standard Pavlovian fear extinction paradigm and an acute pharmacological challenge with oral dronabinol (synthetic THC) in healthy adult volunteers. We examined the effects of THC on vmPFC and HIPP activation when tested for recall of extinction learning 24 h after extinction learning. Compared to subjects who received placebo, participants who received THC showed increased vmPFC and HIPP activation to a previously extinguished conditioned stimulus (CS + E) during extinction memory recall. This study provides the first evidence that pre-extinction administration of THC modulates prefrontal-limbic circuits during fear extinction in humans and prompts future investigation to test if cannabinoid agonists can rescue or correct the impaired behavioral and neural function during extinction recall in patients with PTSD. Ultimately, the cannabinoid system may serve as a promising target for innovative intervention strategies (e.g. pharmacological enhancement of exposure-based therapy) in PTSD and other fear learning-related disorders.
Introduction
Anxiety disorders, such as post-traumatic stress disorder (PTSD), can be conceptualized by an inability to suppress inappropriate fear responses (Rauch, Shin, & Phelps, 2006; Rosen & Schulkin, 1998) . A first-line and empirically-validated approach to treat this disorder is Prolonged Exposure Therapy (PE) (Foa, 2011) , one component of which involves repeated exposure to fear-linked cues to produce ''extinction'' of fear and to prevent avoidance responses to these cues (Hofmann, 2008) . PE is generally effective, but a significant number of patients have incomplete responses or fail to sustain improvements over time (Foa et al., 1999; Hembree et al., 2003; Rothbaum, Astin, & Marsteller, 2005) . Limited efficacy and lack of sustainability could be due to the fact that extinction learning, which is the active ingredient of exposure-based therapy, is vulnerable to the return of fear (Bouton, 2004; Hermans, Craske, Mineka, & Lovibond, 2006; Myers & Davis, 2007; Robbins, 1990) .
Convergent evidence from rat and human work have elucidated that discrete, yet anatomically and functionally interconnected, brain structures are critical for extinction learning and the retention of extinction memory (amygdala [AMYG] , ventromedial prefrontal cortex [vmPFC] , and hippocampus [HIPP]) (for a review see (Milad & Quirk, 2012) ). For instance, AMYG activation has been correlated with fear responses during conditioning in human subjects based on functional magnetic resonance imaging (fMRI) studies (LaBar, Gatenby, Gore, LeDoux, & Phelps, 1998; Phelps, Delgado, Nearing, & LeDoux, 2004; Phelps et al., 2001) . Prefrontal brain regions that interconnect with the AMYG, particularly the vmPFC, are important for consolidation and retrieval of extinction memories and consequent attenuation of conditioned fear responses perhaps via inhibiting AMYG output (Milad & Quirk, 2002; Phelps et al., 2004; Quirk & Mueller, 2008) . In humans, vmPFC activation during extinction recall and vmPFC thickness both correlate with magnitude of extinction retention (Milad, Orr, Lasko, Chang, Rauch, 
